Collaboration news puts Sysmex stock in focus
Sysmex (TSE:6869) is back on investors' radar after VolitionRx Limited announced a collaboration to optimize its Nu.Q NETs H3.1 assay on the Sysmex platform, targeting diseases linked to NETosis.
See our latest analysis for Sysmex.
At a share price of ¥1,424.5, Sysmex has seen modest positive share price momentum in the past month with a 1-month share price return of 3.11% and 90-day share price return of 2.85%, yet the 1-year total shareholder...
J.S.B.Co.Ltd (TSE:3480) has put up a punchy Q2 2026 print, with revenue of ¥29.1b and basic EPS of ¥297.64, set against trailing twelve month EPS growth of 14.1% and a 13.8% annualized earnings growth rate over five years. The company has seen quarterly revenue move from ¥27.0b in Q2 2025 to ¥29.1b in Q2 2026, while basic EPS shifted from ¥267.87 to ¥297.64 over the same period, with trailing twelve month revenue at ¥79.6b and basic EPS at ¥315.17. For investors, the combination of higher...
Kura Sushi (TSE:2695) opened Q2 2026 with revenue of ¥62.3 billion and net income of ¥759 million, set against a trailing twelve month EPS of ¥58.47 and net income of ¥3.49 billion that benefited from a sharp year over year earnings swing. The company has seen quarterly revenue move in a relatively tight band around the ¥59.1 billion to ¥64.1 billion range over the past six reporting periods. EPS has ranged from ¥1.82 to ¥18.95 per quarter, feeding into that higher trailing figure and helping...
Seven & i Holdings has announced an organizational overhaul, creating a new international business management office and international operations department to oversee markets outside Japan and North America, alongside several executive changes effective July 1.
This restructuring highlights management’s effort to tighten global oversight and potentially sharpen execution in overseas convenience and retail operations.
We’ll now examine how the new international business management office and...
Why the HORIBA stock story now starts with biopharma process control
HORIBA (TSE:6856) has moved into focus after FUJIFILM announced a jointly developed inline Raman system that targets real-time control in biopharmaceutical manufacturing, with reported antibody yield gains of about 10% versus conventional methods.
See our latest analysis for HORIBA.
The FUJIFILM partnership arrives against a backdrop of strong momentum in HORIBA’s stock, with a 90 day share price return of 46.60% and a 1...
The Bank of Japan’s latest rate hike to about 1% has put funding costs, inflation risks and the yen back at the center of every Japan investor’s playbook. Higher rates and sticky price pressures can reward some business models and strain others, especially among large manufacturers with meaningful export activity. This article looks at three Japanese export oriented manufacturing stocks from our screener that appear closely exposed to these shifts, and explains how the new rate backdrop, bond...
The Bank of Japan’s latest rate hike to 1% has shifted the ground for income investors, especially anyone focused on Japanese dividend stocks. Higher rates can change how investors weigh cash in the bank against equity income, and they can influence which companies are better placed to handle a gradually tighter money backdrop. This article looks at three stocks from a Japanese Dividend-Paying Stocks screener that are exposed to this rate move. It highlights where the current backdrop may...
As global markets navigate a landscape marked by geopolitical tensions and fluctuating inflation rates, Asia's economic resilience continues to capture investor interest. In this environment, dividend stocks in the region offer an appealing prospect for those seeking steady income streams, particularly as they can provide stability amid market volatility.
As Asian markets navigate a complex landscape marked by geopolitical tensions and economic shifts, investors are increasingly focused on identifying opportunities within this evolving environment. In this context, stocks that may be trading below their estimated value present intriguing possibilities for those looking to capitalize on potential market inefficiencies.
Sekisui House Reit (TSE:3309) has reported its FY 2026 second half results with revenue of ¥22.4b and basic EPS of ¥2,799.0, setting the tone for how the rest of the year is shaping up for holders of the stock. The REIT has seen revenue move from ¥19.7b in FY 2025 second half to ¥22.4b in FY 2026 second half, while basic EPS went from ¥2,320.4 to ¥2,799.0 over the same periods. This gives investors a clear view of how the top line and per unit earnings are tracking. Overall, the release keeps...
Mitsui High-tec (TSE:6966) updated its earnings guidance for the fiscal year ending January 31, 2027, indicating higher expected net sales and profits, supported by demand and currency effects, despite rising material costs.
See our latest analysis for Mitsui High-tec.
The revised guidance has arrived alongside sharp share price momentum, with a 1 day share price return of 15.66% and a 7 day return of 38.50%, contributing to a 30 day gain of 54.10% and a 1 year total shareholder return of...
Ain Holdings earnings and dividend update
Ain Holdings (TSE:9627) released full year results and new guidance that put both earnings and shareholder payouts in focus, giving you fresh numbers to assess the pharmacy and retail operator.
For the year ended April 30, 2026, the company reported sales of ¥647,834 million compared to ¥456,804 million a year earlier. Net income was ¥17,264 million versus ¥9,261 million, with basic earnings per share from continuing operations at ¥491.62 compared to...
As global markets navigate the complexities of geopolitical tensions and inflationary pressures, Asian economies are showing resilience with mixed performances across key indices. In this environment, dividend stocks can offer a stable income stream for investors seeking to balance risk and reward. Identifying well-established companies with consistent dividend payouts may provide a reliable option amidst market volatility.
KanamotoLtd (TSE:9678) has drawn fresh attention after announcing higher interim and projected year end dividends, expanding its share buyback authorization, and reporting half year sales of ¥107,952 million and net income of ¥6,952 million.
See our latest analysis for KanamotoLtd.
At a share price of ¥5,500, KanamotoLtd has delivered a 14.46% 1 month share price return and a 38.19% year to date share price return. The 1 year total shareholder return of 81.74% and 3 year total shareholder...
As global markets navigate a landscape marked by geopolitical tensions and fluctuating inflation rates, Asian equities have shown resilience with mixed performances across key indices. Amid these dynamics, dividend stocks in Asia continue to attract attention for their potential to provide steady income streams and a buffer against market volatility.
Morgan Stanley recently downgraded Sumco Corporation to Underweight from Equalweight on valuation grounds while revising its profit estimates and assumptions, adding to a broader mix of analyst opinions from other brokers such as UBS and Macquarie.
This cluster of conflicting analyst calls has sharpened the market’s focus on how Sumco’s fundamentals, valuation and currency assumptions interact with its wafer growth plans.
Next, we’ll examine how Morgan Stanley’s valuation-driven downgrade,...
In the past year, Toyota Tsusho completed a large share repurchase program, buying 118,095,432 shares, or 11.19% of its stock, for ¥663,696.33 million before closing the plan on June 2, 2026.
The scale of this buyback meaningfully reshapes Toyota Tsusho’s equity base and capital allocation profile, which may influence how investors view its long-term value creation.
We’ll now examine how this very large repurchase, and the resulting reduction in Toyota Tsusho’s share count, affects its...
Mitsui (TSE:8031) lays out its FY 2026 scorecard
Mitsui (TSE:8031) has laid out a full FY 2026 scorecard, with fourth quarter revenue at ¥3.6t and Basic EPS of ¥78.09, set against a trailing 12 month picture that includes revenue of ¥14.0t and Basic EPS of ¥291.12. Over recent periods, the company has seen quarterly revenue range from ¥3.30t to ¥3.64t and Basic EPS move between ¥65.65 and ¥80.73, while trailing 12 month revenue has shifted between ¥13.99t and ¥14.66t and trailing Basic EPS...
FDA clearance puts HOYA (TSE:7741) endoscopy devices in focus
HOYA (TSE:7741) has secured US FDA clearance for new PENTAX Medical i20c Video Endoscope models, giving the company a green light to broaden its gastrointestinal endoscopy offering in US hospitals.
See our latest analysis for HOYA.
The recent FDA clearance arrives after a mixed patch for the stock, with the share price up 9.54% year to date but seeing a 1 month share price return that declined 4.52%, while the 1 year total...
In June 2026, Furukawa Electric Co., Ltd. issued consolidated earnings guidance for the fiscal year ending March 31, 2027, forecasting net sales of ¥1,460.00 billion, operating profit of ¥95.00 billion, and profit attributable to owners of parent of ¥82.00 billion.
This fresh forecast gives investors a clearer view of management’s expectations for profitability, highlighting how Furukawa Electric sees its earnings mix developing over the coming year.
Next, we’ll examine how Furukawa...
MITSUI-SOKO HOLDINGS (TSE:9302) is back in focus after reporting FY2026 revenue and profit growth, with better margins and a stronger balance sheet. The results were supported by steady dividends and a positive management outlook.
See our latest analysis for MITSUI-SOKO HOLDINGS.
At a share price of ¥3,878, MITSUI-SOKO HOLDINGS has had a fairly steady year overall, with modest short term share price gains and a very strong multi year total shareholder return that suggests earlier momentum has...